Differential effects on HIV-1 gene regulation by EBV in T lymphocytic and promonocytic cells transduced to express recombinant human CR2 (CD21)

Virology

Volumn 237, Issue 1, 1997, Pages 23-32

  Romano, Gaetano ^a   Guan, Mingxu ^a   Long, Walter K ^a   Henderson, Earl E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; ETIOLOGY; GENE CONTROL; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL;

HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 0030720914     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8764     Document Type: Article

References (47)

1. Ahearn J. M., Hayward S. D., Hickey J. C., Fearon D. T. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3b receptor. Proc. Natl. Acad. Sci. USA. 85:1988;9307-9311.
2. Carel J. C., Frazier B., Ley T. J., Holers V. M. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells. J. Immunol. 143:1989;923-930.
3. Cepko C. L., Roberts B. E., Mulligan R. C. Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 37:1984;1053-1062.
4. Corsaro C. M., Pearson M. L. Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells. Somatic Cell Genet. 7:1981a;603-616.
5. Corsaro C. M., Pearson M. L. Competence for DNA transfer of ouabain resistance and thymidine kinase: Clonal variation in mouse L-cell recipients. Somatic Cell Genet. 7:1981b;617-630.
6. +. J. Clin. Invest. 99:1997;257-266.
7. Desgranges C., Wolf H., de Thé G., Shanmugaratnam K., Ellouz R., Cammoun N., Klein G., zur Hausen H. Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epi thelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int. J. Cancer. 16:1975;7-15.
8. Fingeroth J. D., Weis J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA. 81:1984;4510-4514.
9. Fischer E., Delibrias C., Kazatchkine M. D. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146:1991;865-869.
10. Gorman C., Padmanabhan R., Howard B. H. High efficiency DNA-mediated transformation of primate cells. Science. 221:1993;551-553.
11. Gosselin J., Menezes J., D'Addario M., Hiscott J., Flamand L., Lamoureux G., Oth D. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur. J. Immunol. 21:1991;203-208.
12. Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313:1985;1564-1571.
13. Hedrick J. A., Lao Z., Lipps S. G., Wang Y., Todd S. C., Lambris J. D., Tsoukas C. D. Characterization of a 70-kDa, EBV gp350/220-binding protein on HSB-2 T cells. J. Immunol. 153:1994;4418-4426.
14. Henderson E. E., Yang J. Y., Zhang R. D., Bealer M. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations. Virology. 182:1991;186-198.
15. Ho A. S., Moore K. W. Interleukin-10 and its receptor. Therapeut. Immunol. 1:1994;173-185.
16. Hofmann A., Nolan G. P., Blau H. M. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA. 93:1996;5185-5190.
17. Iida K., Nadler L., Nussenzweig V. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158:1983;1021-1033.
18. Jones J. F., Shurin S., Abramowsky C., Tubbs R. R., Sciotto C. G., Wahl R., Sands J., Gottman D., Katz B. Z., Sklar J. T-cell lymphomas containg Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 318:1988;733-741.
19. Katsuki T., Hinuma Y., Saito T., Yamamoto J., Hirashima Y., Sudoh H., Deguchi M., Motokawa M. Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis. Int. J. Cancer. 23:1979;746-750.
20. Landers R. J., O'Leary J. J., Crowley M., Healy I., Annis P., Burke L., O'Brien D., Hogan J., Kealy W. F., Lewis F. A., Doyle C. T. Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J. Clin. Pathol. 46:1993;931-935.
21. Levine A. M. AIDS-related malignancies: The emerging epidemic. J. Natl. Cancer Inst. 85:1993;1382-1397.
22. Li Q. X., Young L. S., Niedobitek G., Dawson C. W., Birkenbach M., Wang F., Rickinson A. B. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature (London). 356:1992;347-350.
23. Lin J.-C. The Epstein-Barr virus DNA polymerase transactivates the human immunode ficiency type 1 5′ long terminal repeat. Biochem. Biophys. Res. Commun. 195:1993;242-249.
24. Markowitz D., Goff S., Bank A. A safe packaging cell line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62:1988;1120-1124.
25. Meltzer M. S., Skillman D. R., Hoover D. L., Hanson B. D., Turpin J. A., Kalter D. C., Gendelman H. E. Macrophages and the human immunodeficiency virus. Immunol. Today. 11:1990;217-223.
26. Moore K. W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
27. Ott G., Ott M. M., Feller A. C., Seidl S., Muller-Hermelink H. K. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int. J. Cancer. 51:1992;562-567.
28. Paterson R. L., Kelleher C., Amankonah T. D., Streib J. E., Xu J. W., Jones J. F., Gelfand E. W. Model of Epstein-Barr virus infection of human thymocytes: Expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood. 85:1995;456-464.
29. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfections. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
30. Quinlivan E. B., Holley-Guthrie E., Mar E.-C., Smith M. S., Kenney S. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent. J. Virol. 64:1990;1817-1820.
31. Raab-Traub N., Flynn K., Pearson G., Huang A., Levine P., Lanier A., Pagano J. The differebtiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int. J. Cancer. 39:1987;25-29.
32. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer. 11:1973;499-520.
33. Revoltella R. P., Vigneti E., Fruscalzo A., Park M., Ragona G., Rocchi G., Calef E. Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis. J. Gen. Virol. 70:1989;1203-1215.
34. Ross G. D., Polley M. J., Rabelino E. M., Grey H. M. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J. Exp. Med. 138:1973;798-811.
35. Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A., Kieff E. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:1990;4084-4092.
36. Sinha S. K., Todd S. C., Hedrick J. A., Speiser C. L., Lambris J. D., Tsoukas C. D. Characterization of the EBV/C3b receptor on the human Jurkat T cell line: Evidence for a novel transcript. J. Immunol. 150:1993;5311-5320.
37. Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1984;1225-1230.
38. Soneoka Y., Cannon P. M., Ramsdale E. E., Griffiths J. C., Romano G., Kingsman S. M., Kingsman A. J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
39. Su I.-J., Tsai T.-F., Cheng A.-L., Chen C.-C. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma. J. Am. Acad. Dermatol. 29:1993;685-692.
40. Tedder T. F., Clement L. T., Cooper M. D. Expression of C3b receptors during human B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:1984;678-683.
41. Tierney R. J., Steven N., Young L. S., Rickinson A. B. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:1994;7374-7385.
42. Titti F. A., Borsetti A., Federico M., Testa U., Meccia E., Samoggia P., Peschle C., Verani P., Rossi G. B. Extracromosomial human immunodeficiency virus type 1 DNA forms in fresh peripheral blood lymphocytes and in two interleukin-2-independent T cell lines derived from peripheral blood lymphocytes of an asymptomatic seropositive subject. J. Gen. Virol. 73:1992;3087-3097.
43. von Kalle C., Kiem H. P., Goehle S., Darovsky B., Heimfeld S., Torok-Storb B., Storb R., Schuening F. G. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood. 84:1994;2890-2897.
44. Weis J. J., Tedder T. F., Fearon D. T. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA. 81:1984;881-885.
45. Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320:1989;502-506.
46. Weissman D., Poli G., Fauci A. S. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res. Hum. Retrovir. 10:1994;1199-1206.
47. Weissman D., Poli G., Fauci A. S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. Acq. Immune Def. Synd. Hum. Retrovirol. 9:1995;442-449.